PHARMACODYNAMICS OF CYCLOSPORINE-KETOCONAZOLE INTERACTION IN MICE - COMBINED THERAPY POTENTIATES CYCLOSPORINE IMMUNOSUPPRESSION AND TOXICITY

被引：23

作者：

ANDERSON, JE

MORRIS, RE

BLASCHKE, TF

机构：

[1] STANFORD UNIV,MED CTR,SCH MED,DEPT MED,DIV CLIN PHARMACOL,STANFORD,CA 94305

[2] STANFORD UNIV,MED CTR,SCH MED,DEPT CARDIOVASC SURG,TRANSPLANTAT IMMUNOL LAB,STANFORD,CA 94305

来源：

TRANSPLANTATION | 1987年 / 43卷 / 04期

关键词：

D O I：

10.1097/00007890-198704000-00015

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：529 / 533

页数：5

共 34 条

[1]

ANDERSON JE, 1986, J PHARMACOL EXP THER, V236, P671

[2] CYCLOSPORINE NEPHROTOXICITY [J].

BENNETT, WM ;

PULLIAM, JP .

ANNALS OF INTERNAL MEDICINE, 1983, 99 (06) :851-854

[3] EFFECT OF KETOCONAZOLE ON HEPATIC OXIDATIVE DRUG-METABOLISM [J].

BROWN, MW ;

MALDONADO, AL ;

MEREDITH, CG ;

SPEEG, KV .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1985, 37 (03) :290-297

[4]

CUNNINGHAM C, 1983, TRANSPLANT P, V15, P2712

[5] AMELIORATION OF CYCLOSPORIN-INDUCED NEPHROTOXICITY IN RATS BY INDUCTION OF HEPATIC DRUG-METABOLISM [J].

CUNNINGHAM, C ;

BURKE, MD ;

WHEATLEY, DN ;

THOMSON, AW ;

SIMPSON, JG ;

WHITING, PH .

BIOCHEMICAL PHARMACOLOGY, 1985, 34 (04) :573-578

[6]

DANIELS NJ, 1984, LANCET, V2, P639

[7]

DIEPERINK H, 1982, LANCET, V2, P1217

[8]

FERGUSON RM, 1982, LANCET, V2, P882

[9]

FIDELUS RK, 1983, TRANSPLANT P, V15, P1921

[10] EVALUATION OF CYCLOSPORIN PHENYTOIN INTERACTION WITH OBSERVATIONS ON CYCLOSPORIN METABOLITES [J].

FREEMAN, DJ ;

LAUPACIS, A ;

KEOWN, PA ;

STILLER, CR ;

CARRUTHERS, SG .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1984, 18 (06) :887-893

← 1 2 3 4 →